E1	Condition:T1 Name:T2 Severity:T12
E3	Eq-Comparison:T7 Temporal-Period:T8
E5	Modifier:T11 Modifies:T2
E7	Study:T14 
E8	Procedure:T6 
E9	Drug:T15 Name:T16
E10	Drug:T17 Name:T4
E11	Contraindication:T18 Contraindicates:E10
E12	Procedure:T19 Temporality:E3
E13	Drug:T20 Name:T21
T1	Condition 98 114	plaque psoriasis
T2	Condition-Name 98 114	plaque psoriasis
T3	Life-Stage-And-Gender 25 33	Children
T7	Eq-Comparison 506 511	prior
T8	Eq-Temporal-Period 506 511	prior
T9	Life-Stage-And-Gender 38 49	adolescents
T11	Modifier 73 90	pediatric chronic
T12	Severity 91 97	severe
T14	Study 151 156	study
T6	Procedure 169 178	treatment
T15	Drug 158 168	adalimumab
T16	Drug-Name 158 168	adalimumab
T17	Drug 432 442	adalimumab
T4	Drug-Name 432 442	adalimumab
T18	Contraindication 412 428	contraindication
T19	Procedure 512 521	treatment
T20	Drug 527 537	adalimumab
T21	Drug-Name 527 537	adalimumab
A1	Life-Stage-And-Gender-Type T3 child
A3	Eq-Temporal-Period-Value T8 past
A4	Life-Stage-And-Gender-Type T9 child
A5	Severity-Value T12 severe
R1	Using Arg1:E8 Arg2:E9
R2	Using Arg1:E12 Arg2:E13
R3	Before Arg1:E7 Arg2:E8
R4	Or Arg1:T3 Arg2:T9
R5	And Arg1:T9 Arg2:E1
